CXCL12 and cancer: In breast cancer, it has been found that secondary site tumor colonization during cancer metastasis is not random, but rather there is directed migration of CXCR4-expressing cancer cells towards the SDF-1 ligand at common secondary sites such as lungs and bone marrow [43].